# Loneliness Tracks With Higher Odds of Drug Use in ED Patients

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/ced-loneliness-tracks-with-higher-odds-2026-10-10/
> **Published:** 2026-10-10T22:50:22-04:00 | **Last Modified / Clinically Audited:** 2026-10-10T22:50:22-04:00
> **Clinical Summary:** medical cannabis research: Physician review of Association of loneliness and substance use among emergency department patients.: evidence analysis, dosing co...

---

CED Clinical Relevance #88 Verified Clinical Evidence Primary literature analysis of Association of loneliness and substance use among emergency department patients..

Clinical Insight | CED Clinic
Emergency care often centers on immediate symptoms, while social distress receives less attention. In this sample, loneliness remained associated with illicit drug use after adjustment for demographics, cigarette use, anxiety, and depression symptoms. Each additional UCLA loneliness point corresponded to 7% higher adjusted odds of illicit drug use and 10% higher adjusted odds of opioid use. These are associations, and they cannot establish an individual patient’s probability of harm. A respectful conversation about isolation may identify unmet support needs alongside substance-use screening. Treatment referrals, overdose prevention, and follow-up should depend on the patient’s actual substance exposure, symptoms, preferences, and available resources.

Clinical SciencePeer-ReviewedDosing ContextSafety SignalsPhysician Insight

AudiencePatients, clinicians, healthcare providers, researchers, and policy analysts.
Primary TopicClinical study review: Loneliness Tracks With Higher Odds of Drug Use in .
Source[Read the full source](https://pubmed.ncbi.nlm.nih.gov/42854306/)

Table of Contents

- [Loneliness Tracks With Higher Odds of Drug Use in ED Patients](#Loneliness_Tracks_With_Higher_Odds_of_Drug_Use_in_ED_Patients)[How to Interpret This Clinical Study](#How_to_Interpret_This_Clinical_Study)[Three Rules for Critical Reading](#Three_Rules_for_Critical_Reading)
- [CED Perspective Lens: Eight Clinical Viewpoints](#CED_Perspective_Lens_Eight_Clinical_Viewpoints)[Adjusted Associations With Recent Substance Use](#Adjusted_Associations_With_Recent_Substance_Use)
- [Ask About Connection Without Assigning Blame](#Ask_About_Connection_Without_Assigning_Blame)
- [Cannabis Dosing Remains Outside These Findings](#Cannabis_Dosing_Remains_Outside_These_Findings)
- [Connect Social Assessment With Direct Safety Questions](#Connect_Social_Assessment_With_Direct_Safety_Questions)
- [Screening Policies Need a Usable Referral Path](#Screening_Policies_Need_a_Usable_Referral_Path)
- [Several Pathways Could Explain the Association](#Several_Pathways_Could_Explain_the_Association)
- [Selection, Reporting, and Model Uncertainty Matter](#Selection_Reporting_and_Model_Uncertainty_Matter)
- [Test Whether Assessment Leads to Better Care](#Test_Whether_Assessment_Leads_to_Better_Care)
- [Frequently Asked Questions](#Frequently_Asked_Questions)[Related](#Related)

# Loneliness Tracks With Higher Odds of Drug Use in ED Patients

Among 300 emergency department patients, higher loneliness scores were associated with recent illicit drug use. The findings support attention to social distress, while leaving unanswered whether loneliness screening improves treatment engagement or prevents substance-related harm.

What This Study Teaches Us
Among 300 emergency department patients, each one-point increase in UCLA-20 loneliness score was associated with higher adjusted odds of illicit drug use (1.07, 95% CI 1.03–1.11), opioid use (1.10, 1.03–1.19), crack/cocaine use (1.06, 1.01–1.13), and polydrug use (1.04, 1.01–1.08). The supplied abstract reports no cannabis-specific estimate or clinical intervention outcomes.

Why This Matters
Loneliness may identify an unmet social need among emergency department patients who report substance use, even after adjustment for anxiety and depression symptoms. Clinicians can explore that need alongside direct substance-use assessment, while screening programs still require evidence of benefit.

Study SnapshotPost TypePhysician-Guided Clinical Science Deep DivePrimary SourceThe American journal of emergency medicinePublication Date2026Oct03Evidence LevelJournal ArticleFocus AreaLoneliness Tracks With Higher Odds of Drug Use in ED PatientLead AuthorsDana L Sacco, Quinn R Anderson, Kechna Cadet, Corianna E Sichel et al.DOI10.1016/j.ajem.2026.09.061PMIDPMID: 42854306

Clinical Bottom Line
This study review translates complex data into practical clinical insights, maintaining realistic therapeutic expectations.

Headline vs. Reality Truth Meter | Clinical Analysis

**Mainstream Media Claim:** Potential headline framing: Loneliness causes drug use, and emergency departments can prevent addiction by screening for it. No specific news report was supplied for comparison.

**Primary Journal Data:** The supplied abstract describes 300 adults recruited by convenience sampling from one urban academic emergency department. Each one-point increase on the UCLA-20 loneliness scale was associated with higher adjusted odds of illicit drug use: aOR 1.07, 95% CI 1.03–1.11. Associations were also reported for opioids, crack/cocaine, and polydrug use. Screening effectiveness, addiction prevention, and treatment outcomes were not measured.

**Dr. Caplan’s Clinical Verdict:** Loneliness deserves a place in a compassionate social assessment. These findings support further evaluation of screening and referral approaches, but they do not establish a causal pathway or a proven prevention strategy.

Primary Analysis | Association of loneliness and substance 

**Study Overview:** Loneliness is associated with numerous adverse health outcomes. However, little is known about its relationship with substance use among emergency department (ED) patients, a population at elevated risk for substance use and related harms. We examined associations between loneliness and past 90-day substance use among ED patients. A convenience sample of patients aged 18-75 years was recruited from an urban academic ED between March 2025 and January 2026 (N = 300). Loneliness was assessed using the UCLA Loneliness Scale (UCLA-20; range = 20 to 80). The Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) tool assessed binge alcohol use, cannabis use, and illicit drug use, including crack/cocaine, sedatives/hypnotics, opioids, and polydrug use. Multivariable logistic regression models examined associations between loneliness and substance use outcomes, adjusting for demographic characteristics, cigarette use and anxiety and depression symptoms. Each one-point increase in loneliness was associated with greater odds of illicit drug use (adjusted odds ratio [aOR] = 1.07, 95% confidence interval [CI]:1.03-1.11), including use of opioids (aOR = 1.10, 95% CI:1.03-1.19), crack/cocaine (aOR = 1.06, 95% CI:1.01-1.13), and polydrug use (aOR = 1.04, 95% CI:1.01-1.08). Loneliness was independently associated with recent illicit drug use. These findings suggest that loneliness may be an important and underrecognized correlate of high-risk substance use in ED populations. Incorporating loneliness assessment into ED screening workflows may help identify patients at elevated risk for substance-related harms and inform interventions aimed at improving engagement with substance use treatment and supportive services.

**Primary Source & Scope:** Published in *The American journal of emergency medicine* (2026Oct03) conducted by Dana L Sacco, Quinn R Anderson, Kechna Cadet, Corianna E Sichel et al.. [Primary Source Link](https://pubmed.ncbi.nlm.nih.gov/42854306/) | **Primary Record:** DOI: 10.1016/j.ajem.2026.09.061 | PMID: 42854306

How Strong Is This Evidence?
This observational study used established assessment tools and multivariable logistic regression in 300 emergency department patients, with confidence intervals that excluded 1.0 for the reported associations. A single-site convenience sample and absent outcome-specific event counts limit assessment of model stability, while the supplied abstract provides insufficient detail on missing data, model assumptions, and multiple-comparison handling.

Where This Paper Deserves Skepticism
Participation and emergency department attendance may select patients whose social circumstances and substance-use patterns differ from the wider population. Self-reported recent use is vulnerable to recall and disclosure bias, and housing instability, pain, trauma, or other unmeasured factors could influence both loneliness and substance use. The timing of the assessments cannot establish causal direction from the information supplied.

What This Paper Does Not Show
The study does not prove that loneliness causes substance use, that treating loneliness reduces drug use, or that screening prevents overdose. It does not establish a cannabis effect, a cannabinoid dosing strategy, or a validated threshold for clinical or regulatory decisions.

How This Fits With the Broader Clinical Conversation

Clinical research into Association of loneliness and substance use among is progressing through rigorously documented peer-reviewed cohorts.

Evaluating primary evidence enables clinicians to tailor care plans while respecting therapeutic boundaries.

Editorial Commentary

*From a clinical perspective, Association of loneliness and substance use among emergency department patients. underscores the necessity of evaluating primary data rather than commercial headlines.*

*Clinicians discussing these findings should ground patient recommendations in individualized care, verified formulation standards, and monitored therapeutic outcomes.*

What a Careful Reader Should Take Away
Ask about loneliness with curiosity and without assumptions, then assess substance exposure and safety directly. Use the findings to support a conversation about accessible care, not to predict addiction or change cannabis dosing.

[https://cedclinic.com/ask](https://cedclinic.com/ask)Ask about this study:[🧠Anxiety and Mood](https://cedclinic.com/ask)[🛡️Use Disorder](https://cedclinic.com/ask)[🛡️Safety](https://cedclinic.com/ask)[🔎This study's limits](https://cedclinic.com/ask)

Evidence Interpretation Guide

## How to Interpret This Clinical Study

Navigating biomedical publications regarding Association of loneliness and substance use a requires reviewing study methodology and patient eligibility.

### Three Rules for Critical Reading

**Critical Rule**Read each adjusted odds ratio as a per-point association on the UCLA-20 scale, and distinguish odds from absolute probability.

**Critical Rule**Check outcome-specific event counts, confounder selection, missing-data handling, and model assumptions in the full paper before judging predictive usefulness.

**Critical Rule**Separate the reported illicit-drug findings from unreported cannabis and alcohol results, and require intervention evidence before claiming screening improves outcomes.

Key Evaluation Question
Does loneliness assessment add useful information beyond existing substance-use screening, and does acting on that information improve patient outcomes?

The Patient Question
Could feeling isolated be affecting my substance use or access to care, and what support options are available to me?

The Bottom Line
Higher loneliness scores were associated with recent illicit drug use in this emergency department sample; causation, screening benefit, and cannabis-specific implications remain unresolved.

CED Perspective Lens

## CED Perspective Lens: Eight Clinical Viewpoints

Analyzing evidence across clinical, patient, safety, dosing, and physiological perspectives

Lens OverviewEight structured clinical perspectives synthesizing primary study data for patient care.

#### Adjusted Associations With Recent Substance Use

The investigators recruited 300 adults aged 18–75 from an urban academic emergency department between March 2025 and January 2026. Loneliness was measured with the UCLA-20 scale, and the TAPS tool assessed substance use during the previous 90 days. Models adjusted for demographic characteristics, cigarette use, anxiety, and depression symptoms.

For every additional loneliness point, adjusted odds increased for illicit drug use, opioids, crack/cocaine, and polydrug use. The reported confidence intervals excluded 1.0. Absolute substance-use frequencies and outcome-specific event counts were absent from the supplied abstract, so the findings cannot establish individual risk or the precision of a clinical screening threshold.

Lens takeawayHigher loneliness scores identified an associated pattern of recent drug use, with important uncertainty about absolute risk and screening performance.

#### Ask About Connection Without Assigning Blame

Patients may experience loneliness despite living with others or having frequent social contact. A clinician can ask whether the patient feels supported, has someone to contact during a difficult moment, or faces barriers to treatment. These questions should remain separate from assumptions about drug use, character, or readiness for change.

The association persisted after adjustment for anxiety and depression symptoms. That finding supports attention to loneliness as a distinct concern, although symptom adjustment cannot remove every shared influence. A patient who reports isolation may benefit from an individualized discussion of practical support, behavioral health care, and substance-use services when relevant.

Lens takeawayUse loneliness questions to understand unmet needs, and base substance-use care on direct assessment and the patient’s priorities.

#### Cannabis Dosing Remains Outside These Findings

Cannabis use was assessed with the TAPS tool, but the supplied abstract provides no cannabis-specific effect estimate or confidence interval. It also provides no cannabinoid dose, THC-to-CBD ratio, administration route, product composition, or treatment indication. A cannabis association cannot be assumed from the reported associations with opioids or crack/cocaine.

For patients using medical cannabis, dosing decisions still require the usual clinical assessment: treatment goals, response, adverse effects, concurrent medications, and impairment risk. Loneliness alone supplies no basis for increasing THC, selecting CBD, or recommending a particular formulation. Social support needs should be addressed directly while the cannabis regimen receives its own safety review.

Lens takeawayThis study provides no cannabis dosing guidance, and its illicit-drug associations cannot establish a benefit from any cannabinoid formulation.

#### Connect Social Assessment With Direct Safety Questions

The opioid association was the largest reported per-point estimate: aOR 1.10, with a 95% confidence interval of 1.03–1.19. This result concerns reported opioid use. It does not quantify overdose, opioid use disorder, withdrawal, or exposure to fentanyl. Those concerns require direct questions and clinical evaluation.

When opioid exposure is identified, appropriate care may include overdose education, naloxone access, and assessment for evidence-based treatment. Polydrug use warrants clarification of the actual substances and combinations involved.

Loneliness can inform a conversation about who could help during an emergency. The study did not establish that a loneliness score predicts acute toxicity or determines discharge safety.

Lens takeawayAssess overdose and interaction risks from actual substance exposure, while using social questions to identify gaps in practical support.

#### Screening Policies Need a Usable Referral Path

An emergency department considering loneliness assessment needs a clear response to a positive result. Staff time, patient privacy, referral availability, and follow-up capacity all affect whether screening can help. The study suggests a possible assessment target, but it does not supply a validated cutoff or an implementation protocol.

Institutional policies should protect sensitive social and substance-use information and explain how it will support care. A loneliness score should not become a gatekeeping rule for medication, discharge, or access to treatment. Evaluation should measure whether patients reach services and experience better outcomes, alongside the time and burden imposed by screening.

Lens takeawayAny loneliness screening policy should pair respectful assessment with accessible services and a plan to measure patient-centered outcomes.

#### Several Pathways Could Explain the Association

Loneliness could influence substance use through distress, coping behavior, or reduced access to supportive relationships. Substance use could also disrupt relationships and increase isolation. Shared circumstances, including housing instability, chronic pain, trauma, or financial strain, could contribute to both. These are possible explanations, not mechanisms demonstrated by the reported data.

Adjustment for anxiety and depression symptoms addresses part of this overlap, but it cannot determine which experience came first. The study reports no stress biomarkers, reward-system measurements, or repeated assessments of social connection. Biological explanations therefore remain hypotheses that require separate investigation and evidence.

Lens takeawayThe association is compatible with several causal pathways, and the reported measurements cannot distinguish among them.

#### Selection, Reporting, and Model Uncertainty Matter

Convenience recruitment at one urban academic emergency department limits generalizability. Patients who were available and willing to participate may differ from those who were critically ill, unable to consent, or absent during recruitment. The supplied abstract does not describe participation rates or the clinical reasons for emergency visits.

Substance-use reporting can be affected by recall and concern about disclosure. Outcome-specific event counts, missing-data handling, and model diagnostics are not provided. Several related outcomes were analyzed, and the abstract does not describe adjustment for multiple comparisons. Residual confounding and uncertain timing further limit causal interpretation despite the statistically significant estimates.

Lens takeawayThe reported associations merit attention, but selection effects, self-report, and incomplete model details limit their use in individual prediction.

#### Test Whether Assessment Leads to Better Care

A useful next study would follow patients over time to examine whether loneliness precedes changes in substance use, whether substance use precedes loneliness, or whether both change together. Recruitment across multiple emergency departments would help test whether the associations extend to different patient populations and care settings.

A screening trial could compare routine care with a defined loneliness assessment and referral pathway. Meaningful endpoints would include completed treatment visits, patient-reported support, repeat emergency visits, and substance-related harm.

Cannabis-specific analyses should report effect estimates and distinguish therapeutic use from other use patterns. Product exposure and reasons for use would help connect any association to clinical decisions.

Lens takeawayFuture research should test timing, referral effectiveness, and patient outcomes before loneliness screening becomes a routine substance-use intervention.

Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

 

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.

 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 

 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](http://CEDclinic.com/book)
 [Cannabis Care](http://CEDclinic.com/book)
 
 

 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

Share this Evidence Watch

[X](https://twitter.com/intent/tweet?text=Loneliness+Tracks+With+Higher+Odds+of+Drug+Use+in+ED+Patients&url=https%3A%2F%2Fcedclinic.com%2Fced-loneliness-tracks-with-higher-odds-2026-10-10%2F)
[LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fced-loneliness-tracks-with-higher-odds-2026-10-10%2F)
[BlueSky](https://bsky.app/intent/compose?text=Loneliness+Tracks+With+Higher+Odds+of+Drug+Use+in+ED+Patients%20https%3A%2F%2Fcedclinic.com%2Fced-loneliness-tracks-with-higher-odds-2026-10-10%2F)
[Instagram](https://www.instagram.com/drcaplan/)
[Substack](https://doctorapprovedcannabis.substack.com/)
[RSS](https://cedclinic.com/feed/)

Source: [Primary Source: Association of loneliness and substance use among emergency department patients.](https://pubmed.ncbi.nlm.nih.gov/42854306/)

Related Reading at CED ClinicContinue exploring the evidence[Cannabis Use Disorder Is Rising Among US Adults](https://cedclinic.com/cannabis-use-disorder-rising-us-adults-2026/)

More on this topic: Epidemiological evaluation of diagnostic trends, screening tools, and evidence-based patient counseling.

[More on this topic: CUD trends & screening](https://cedclinic.com/cannabis-use-disorder-rising-us-adults-2026/)[PP-01 for Cannabis Withdrawal: What a 14-Person Trial Found](https://cedclinic.com/pp01-cannabis-withdrawal-proof-of-concept/)

More on this topic: Clinical trial data evaluating pharmacological interventions and supportive care for cannabis withdrawal.

[More on this topic: Withdrawal management](https://cedclinic.com/pp01-cannabis-withdrawal-proof-of-concept/)[Pancreatic Cancer Cannabis Trial Finds Modest THC Dose Signals for Anxiety and Sleep](https://cedclinic.com/ced-pancreatic-cancer-cannabis-trial-fi-2026-09-22/)

More on this topic: Physician appraisal of adjunctive cannabinoid therapies in oncology, [symptom management](https://cedclinic.com/cbd-gummies-tinnitus-evidence/), and anxiety.

[More on this topic: Cannabinoids in oncology](https://cedclinic.com/ced-pancreatic-cancer-cannabis-trial-fi-2026-09-22/)

## Frequently Asked Questions

Does this study show that loneliness causes drug use?

No. It reports an association between loneliness scores and substance use during the previous 90 days. The supplied findings cannot establish which came first or exclude shared causes.

What does an adjusted odds ratio of 1.07 mean?

Each one-point increase in loneliness was associated with 7% higher odds of illicit drug use after adjustment for the listed covariates. Odds are different from probability, so this does not mean a seven-percentage-point increase in risk.

How many patients participated, and where were they recruited?

The sample included 300 adults aged 18–75 recruited from one urban academic emergency department between March 2025 and January 2026. Recruitment used a convenience sample.

Was the association explained entirely by anxiety or depression?

The reported association remained after statistical adjustment for anxiety and depression symptoms. That adjustment does not eliminate all possible mental health influences, measurement error, or other confounding.

Which substances had reported associations with loneliness?

The abstract reports associations for illicit drug use overall, opioid use, crack/cocaine use, and polydrug use. Their adjusted odds ratios per loneliness point were 1.07, 1.10, 1.06, and 1.04, respectively.

Did the researchers find an association with cannabis?

Cannabis use was measured, but a cannabis-specific result is absent from the supplied abstract. Its omission cannot establish either an association or a null finding.

Should a lonely patient change their medical cannabis dose?

These findings provide no basis for a cannabis dose change. A clinician should review the treatment indication, benefit, adverse effects, other medications, and impairment risk while addressing social concerns separately.

Can a loneliness score diagnose addiction?

No. This study supplies no diagnostic threshold or validated prediction rule. Substance use disorder assessment requires evaluation of impaired control, consequences, and other diagnostic criteria.

Should every emergency department start loneliness screening now?

The findings support evaluating that approach, but they do not establish universal screening effectiveness. Any program needs a practical referral pathway, privacy protections, and measurement of patient outcomes.

What should a patient discuss with their clinician?

Discuss feeling isolated, the substances and medications used, reasons for use, and barriers to getting support. If opioid exposure is present, ask about naloxone, overdose prevention, and treatment options when appropriate.

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).